Global Health Limited

rs,

ef:- GHL/2022-23/EXCH/024 The General Manager Dept. of Corporate Services BSE Limited, P J Towers, Dalal Street, Mumbai - 400 001 The Manager Listing Department National Stock Exchange of India

4.7 million

o 3,500+ by FY2025E 69 operation theatres 550+ ICU beds Facilities for 30+ medical specialties 4.7 million sq. ft. of built-up area with additional land for expansion * As at December 31, 2022 9,100+ fu

2 million

know, Indore, Ranchi are NABH accredited Patients treated Seen as the ‘last stop’ in healthcare 2 million+ patients treated annually 1,00,000+ procedures annually Patients treated from over 130 countrie

rs 384

Non-invasive alternative to surgery for the treatment of both cancerous and non- cancerous tumours 384-Slice CT Advanced AI based CT scanner for highly accurate CT procedures and better evaluation o

400 million

are installed beds as at December 31, 2022 19 Diversified group of hospitals across 5 States Over 400 million people live in the States with Medanta facilities Gurgaon; Largest single location private hospi

22%

950 4 5 3 6 1 2 Diversification | Gurgaon vs. other units Installed capacity No. of beds 22% 1,722 78% 46% 2,571 54% FY 19 9M FY 2023 Patna; Largest private hospital in Patna with pl

78%

3 6 1 2 Diversification | Gurgaon vs. other units Installed capacity No. of beds 22% 1,722 78% 46% 2,571 54% FY 19 9M FY 2023 Patna; Largest private hospital in Patna with planned bed ca

46%

1 2 Diversification | Gurgaon vs. other units Installed capacity No. of beds 22% 1,722 78% 46% 2,571 54% FY 19 9M FY 2023 Patna; Largest private hospital in Patna with planned bed capacit

54%

sification | Gurgaon vs. other units Installed capacity No. of beds 22% 1,722 78% 46% 2,571 54% FY 19 9M FY 2023 Patna; Largest private hospital in Patna with planned bed capacity of 650 R

10%

increase presence in Indore1 Notes: 1. Refer slide #40 2. As per internal estimates (unaudited) 10% 15,060 90% FY 19 33% 20,273 67% 9M FY 2023 Gurgaon Other units 20 Experienced senior man

90%

sence in Indore1 Notes: 1. Refer slide #40 2. As per internal estimates (unaudited) 10% 15,060 90% FY 19 33% 20,273 67% 9M FY 2023 Gurgaon Other units 20 Experienced senior management team

33%

ore1 Notes: 1. Refer slide #40 2. As per internal estimates (unaudited) 10% 15,060 90% FY 19 33% 20,273 67% 9M FY 2023 Gurgaon Other units 20 Experienced senior management team across units

“Khilnani will be supported by eminent pediatric critical care specialist Dr.”

“~70% of the planned bed addition will be at existing 100% and 60% respectively hospitals; resulting in lower capex / bed • Hospital to commence operations with 300 • Floor area of 100K+ sq.”

“meter; along with additional land bank of 13 beds in FY25 acres available at Gurugram for ancillary services 39 New asset light hospital partnership in Indore Capitalizing on existing brand and growing market in Indore Proposed hospital design About the project • Site identified in prominent location on MR 10 road • O&M project with partner building ‘warm shell’ • Total operational area of ~5 lakh sq.”

Notes

2

Sub

1

CABG on oldest patient

1

First lung transplant at Medanta

1

Sub

Investor Presentation Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of Investor Presentation for the Quarter III & Nine Months ended December 31, 2022 financial results of the Company. Kindly take the above on record. For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M. No. A17035 Encl: a/a Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 GLOBAL HEALTH LIMITED Dedicated to Life INVESTOR PRESENTATION Q3 FY 2023 5 1 Disclaimer from historical This presentation, apart information, contains some "forward-looking statements" including those describing the Company’s strategies, strategic direction, future prospects, estimates etc. These forward-looking statements involve a objectives, number of risks, uncertainties and other factors that could cause ac

CABG on oldest patient

98 year old Iraqi undergoes bypass surgery 14 Italians with Coronavirus shifted to Medanta Gurgaon (among the first Covid patients in India) India’s first three-way swap liver transplant at Medanta saves three lives An illustrative list of some significant clinical accomplishments 16 Medanta: Recognised for its clinical excellence both in India and globally Best Private Hospital in India three years in a row • Newsweek ranking as the Best Private Hospital in India three years in a row: 2020, 2021 and 2022 • Only Indian private hospital to be featured in the Top 200 hospitals of the world, 2021 and 2022 Amrit Ratna Samman by News 18 on India’s 75th Independence Day All India Critical Care Hospital Ranking Survey 2022 by Times Health Survey National and International Quality Accreditations 17 03 Medanta Today Leading tertiary and quaternary service provider in India 18 From our flagship Medicity campus in Gurgaon, we have grown to over ~2,500 beds across 5 cities Largest private hospital

Notes

1. Refer slide #40 2. As per internal estimates (unaudited) 10% 15,060 90% FY 19 33% 20,273 67% 9M FY 2023 Gurgaon Other units 20 Experienced senior management team across units Clinical department heads chair operating and governance committees in each unit Dr. Naresh Trehan Chairman and Managing Director Pankaj Sahni Group CEO & Director Sanjeev Kumar Group CFO Sumanta Ray Chief Marketing and Growth Officer Bhuvander Kaul Chief Procurement Officer Dr Sandeep Sawhney SVP Strategy & Planning Rajiv Sikka Chief Information Officer Manoj Gupta SVP and Head HR Richa Singh General Counsel Rahul Ranjan Company Secretary Ambili Vijayaraghavan Hospital Director, Gurgaon Dr Rakesh Kapoor Medical Director, Lucknow Dr. Ravi Shankar Medical Director, Patna Dr. Sandeep Srivastava Medical Director, Indore Vishvajeet Kumar Hospital Director, Ranchi 21 Eminent Board of Directors Marquee domestic and foreign institutions as major shareholders Board of Directors Dr. Naresh Trehan Chairman and Managing D

First lung transplant at Medanta

patient underwent a double lung transplant Medanta pioneers advanced version of TAVI technique to treat aortic stenosis in patients with small vessels using Evolut Pro + TAVI technique Medanta Gurugram completed 500 BMT procedures (adult and pediatrics) till August 2022 Medanta Lucknow completed 100+ Kidney Transplants till August 2022 and 25 Liver transplants in less than one year Medanta becomes the first private hospital in North India to launch Drug Resistant Tuberculosis clinic Dr. Sudipto Pakrasi had introduced the cutting-edge technology of Robotic Cataract surgeries, completed 4,000 cases of Femto Laser Assisted Cataract surgeries (FLACS), highest by a single surgeon in India India’s first three-way swap liver transplant saves three lives 26 Key operating metrics: Revenue and profitability Robust growth across all major metrics Total Income (INR million) EBITDA (INR million and margin %) +21.2% 20,273 16,727 +22.1% 4,856 3,976 +19.0% 6,946 7,062 5,934 +17.9% 1,721 1,719 1,458 Q

Notes

1. Revenue from healthcare services excludes pharmacy revenue and other income 2. Revenue breakdowns are provided as per internal MIS at the Company’s consolidated level 3. Cancer includes medical oncology, radiation oncology, head & neck surgery, bone marrow transplant and breast surgery 30 Growth seen in both mature and new hospitals New hospitals continue to show strong success in a very short timeframe Matured hospitals - Over 6 years Developing hospitals - Less than 6 years Total Income (INR million) EBITDA (INR million and margin %) Total Income (INR million) EBITDA (INR million and margin %) +8.2% 13,768 14,901 +0.4% 3,316 3,330 +82.0% 5,401 2,967 +131.4% 1,534 663 9M FY22 9M FY23 9M FY22 9M FY23 9M FY22 9M FY23 9M FY22 9M FY23 24.1% 22.3% 22.3% 28.4% Occupied Bed Days ARPOB* (INR) Occupied Bed Days ARPOB* (INR) -3.6% 244,638 235,904 +10.7% 53,832 59,607 +78.2% +2.6% 92,349 54,498 55,911 51,809 9M FY22 9M FY23 9M FY22 9M FY23 9M FY22 9M FY23 9M FY22 9M FY23 63% 59% 51% 60% *ARPO